Healthcare

Patients ‘May Need to Stockpile Own Drugs’ If No-Deal Brexit Looms

October 29, 2018

If the U.K. leaves the EU with no deal, it could be “catastrophic” for medicine supplies — and necessitate emergency powers, the pharmaceuticals industry says.

Opinion

Drug Companies, Not 'Middlemen', Are Responsible for High Drug Prices

October 25, 2018

Forbes

As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.

Think Tank

How a ‘Value-Based’ Approach Is Transforming Healthcare Services and Supply Chains

October 22, 2018

Robert J. Bowman, SupplyChainBrain

Certain shifts in business strategy seem so shockingly obvious in retrospect that you have to wonder why they weren’t common practice all along.

Nafta by Any Other Name Is Just Fine With Corporate America

October 4, 2018

Bloomberg

The sky isn’t falling. That’s the message coming from Corporate America after President Trump reached a deal to revise the North American Free Trade Agreement.

Blockchain Hype May Finally Turn Into Reality in Pharmaceuticals

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.

September 26, 2018

Bloomberg

Blockchain believers have delivered little more than hype, mostly failing to get it deployed outside the cryptocurrency space where the technology was developed. But a little-noticed U.S. law could change that, bringing the ledger system to the pharmaceutical business.

Companies Stockpile Drugs, Chocolate as They Brace for ‘Hard’ Brexit

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

September 20, 2018

The Wall Street Journal

Some of the world’s biggest companies are drawing up plans for the unplannable: a March divorce between Britain and the European Union, in which even some basic parameters have yet to be hammered out.

When Your Prescription Drug Is Tainted With a Chemical 'Used to Make Rocket Fuel'

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

September 12, 2018

Los Angeles Times

Wayne Pearl, like millions of people with high blood pressure, takes the widely prescribed generic drug valsartan.

Hospitals Are Fed Up With Drug Companies, So They're Starting Their Own

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.

September 7, 2018

Los Angeles Times

A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a not-for-profit generic drug company, Civica Rx, to take some control over the drug supply.

Pfizer's Costly Divorce: Pharma Giant Says Brexit Will Cost It $100M

European companies aren’t alone in their Brexit pain. Pfizer, the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m.

September 5, 2018

Fortune

European companies aren’t alone in their Brexit pain. Pfizer, the U.S.-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m.